We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

DIASYS DIAGNOSTIC SYSTEMS

Develops, manufactures, and distributes diagnostic systems for clinical chemistry and immunoturbidimetry. Supplies hi... read more Featured Products: More products

Download Mobile App





DiaSys Showcases High Quality Clinical Chemistry Solutions at WHX Labs Dubai

By LabMedica International staff writers
Posted on 10 Feb 2026

At WHX Labs Dubai 2026, DiaSys Diagnostic Systems GmbH (Holzheim, Germany) is presenting a comprehensive portfolio of diagnostic solutions focused on clinical chemistry and immunoturbidimetry. More...

Exhibiting at booth S2.E50, the company highlights more than three decades of experience supplying laboratories in over 140 countries worldwide. Visitors to the company's booth can experience live demonstrations and learn about DiaSys's latest innovations that support laboratories throughout the world.

At its booth, DiaSys showcases its instrumentation portfolio of automated clinical chemistry analyzers that provide efficient and reliable testing options for small to medium-sized laboratories. This includes the respons® c-line series, featuring the respons® 240c, respons® 420c, and respons® 600c analyzers. In addition, the portfolio includes dedicated systems such as the respons® A1c for HbA1c testing and the respons® UDS100 for urine diagnostics.

DiaSys is also highlighting its broad portfolio of more than 90 ready-to-use reagents, spanning routine clinical chemistry, lipid testing, liver and kidney function, coagulation-related markers, inflammatory biomarkers, and specialized immunoturbidimetric assays. The reagent range is complemented by calibrators and controls, enabling complete, traceable, and quality-assured system solutions for clinical laboratories.

The portfolio is further supported by DiaSys’s TruCal® calibrators and TruLab® quality control materials, which support standardized workflows, traceability, and consistent analytical performance across clinical chemistry testing.

Related Links: 
DiaSys Diagnostic Systems

Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.